Both in Pharmaceuticals
CAMP4 Therapeutics vs Vanda Pharmaceuticals
Over the past year CAMP returned −6.6% and VNDA returned −28.3%; their daily moves had a correlation of 0.22.
CAMP −6.6% VNDA −28.3%Growth of $1, one year, split-adjusted
| Metric | CAMP | VNDA |
|---|---|---|
| Price | $3.65 | $4.00 |
| Market cap | $229.0M | $241.9M |
| Today | 0.00% | +0.25% |
| 1 month | −6.6% | −20.5% |
| 6 months | −9.0% | −43.3% |
| Year to date | −40.5% | −54.6% |
| 1 year | −6.4% | −28.7% |
| Revenue growth (YoY) | +18.8% | −3.9% |
| Gross margin | 100.0% | 93.0% |
| Net margin | −1884.8% | −123.7% |
| P/E (TTM) | — | — |
| Price / sales | 54.3× | 1.1× |
| Net cash | $86.4M | $166.9M |
| Dividend yield | — | — |
| Volatility (60d) | 86.6% | 37.0% |
| Short % of float | 8.2% | 15.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).